AzTrials
AzTrials

ChildNCT04403178

Prevention of Hip Displacement in Children With Cerebral Palsy in Denmark

An observational study of Child and Cerebral Palsy, run by Mette Røn Kristensen at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Children with cerebral palsy have an increased risk of hip dislocation, which is a painful and severe complication of cerebral palsy. The 20-years evaluation of the Swedish surveillance programme shows that hip dislocation in children with cerebral palsy can be prevented with regular clinical and radiographic… Read more about this study

Who is it for?
Any age
Conditions the study is for
Child, Cerebral Palsy, Radiography
What is being tested?
Radiographic examination with a Migration of > 40 %
How many people
300 participants
Where
1 siteDenmark
Study dates
1 Jan 2008to 27 Dec 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Children with cerebral palsy in Denmark. Data will be obtained from the national clinical quality database the Danish Cerebral Palsy Follow-up Program and the Danish National Patient Register.

Who may be able to join

  • Children with cerebral palsy
  • Gross Motor Function Classification System III to V
  • Migration Percentage < 40 % for both hips at the first pelvic radiographic examination

Who cannot join

  • Previous femoral osteotomy
  • Previous pelvic osteotomy
  • Previous selective dorsal rhizotomy
  • Intrathecal baclofen pump treatment
  • Children whose diagnosis was not confirmed
  • Children who were no longer followed in the children's ward at the hospital
  • Children who moved out of the area
  • Children who died during the study period

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Fysio- og Ergoterapien, afsnit 234-236, Hvidovre hospital

    Hvidovre, Capital Region, 2650

Other trials in Denmark

About this study

Official title: Prediction of Hip Displacement in Children With Cerebral Palsy Among Patients Participating in the Danish Cerebral Palsy Follow-up Program

Children with cerebral palsy have an increased risk of hip dislocation, which is a painful and severe complication of cerebral palsy. The 20-years evaluation of the Swedish surveillance programme shows that hip dislocation in children with cerebral palsy can be prevented with regular clinical and radiographic examination and early intervention.

We would like to determine the individual risk for hip displacement for Danish children with CP in The Danish Cerebral Palsy Follow-up Program. This could be a valuable clinical tool in deciding on further follow-up and treatment.

Read the detailed description

Migration percentage (MP) which is measured from the pelvis radiograph is commonly used to assess lateral displacement of the femoral head and is being used in the Swedish and in the Danish surveillance programme. Most children with an MP > 40 % need surgery to prevent further displacement and prevent dislocation of the hip. In the Swedish surveillance programme they have developed the Cerebral Palsy Follow-Up Programme (CPUP) hip score as a risk score to determine which children are at high or low risk for hip displacement (MP > 40 %) within five years after first radiographic examination.

The aim of this study is to predict the likelihood that a child with cerebral palsy will develop hip displacement (MI> 40) within three years. The design is a prediction study.

Data will be obtained from the national clinical quality database the Danish Cerebral Palsy Follow-up Program and the Danish National Patient Register.

Being tested
Radiographic examination with a Migration of > 40 %
Medical subject headings
Cerebral Palsy, Hip Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiographic examination with a Migration of > 40 %Diagnostic test

    Radiographic examination

Study groups in NCT04403178
Study groupRoleWhat they receive
Children who develops hip displacementPatient group 1 includes children who developed a Migration Percentage of > 40 % in either hip over a follow-up period of three years.
Children who do not develops hip displacementPatient group 2 includes children who did not develop a Migration Percentage of > 40 % on either hip over a follow-up period of three years
Receives: Diagnostic Test: Radiographic examination with a Migration of > 40 %

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Development of hip displacement or not measured by the Migration Percentage

    Migration Percentage (MP) is measured from a pelvis radiograph and is used to assess lateral displacement of the femoral head. A MP < 40 % on either hip is a good outcome, whereas a MP > 40 % on either hip is a worse outcome.

    Measured: Follow-up period of three years.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 May 2020
  2. Study start1 Jan 2008
  3. Primary completion27 May 2020
  4. Study completion27 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04403178
Sponsor's protocol ID
P-2019-143 2
Status last verified
Jul 2020
First submitted
15 May 2020
Last updated
29 Jul 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Hermanson M, Hagglund G, Riad J, Rodby-Bousquet E, Wagner P. Prediction of hip displacement in children with cerebral palsy: development of the CPUP hip score. Bone Joint J. 2015 Oct;97-B(10):1441-4. doi: 10.1302/0301-620X.97B10.35978.

    PubMed 26430023
  • Rasmussen HM, Nordbye-Nielsen K, Moller-Madsen B, Johansen M, Ellitsgaard N, Pedersen CR, Rackauskaite G, Engberg H, Pedersen NW. The Danish Cerebral Palsy Follow-up Program. Clin Epidemiol. 2016 Oct 25;8:457-460. doi: 10.2147/CLEP.S99474. eCollection 2016.

    PubMed 27822084
  • Hagglund G, Alriksson-Schmidt A, Lauge-Pedersen H, Rodby-Bousquet E, Wagner P, Westbom L. Prevention of dislocation of the hip in children with cerebral palsy: 20-year results of a population-based prevention programme. Bone Joint J. 2014 Nov;96-B(11):1546-52. doi: 10.1302/0301-620X.96B11.34385.

    PubMed 25371472

Questions about this trial

What is this clinical trial studying?

An observational study of Child and Cerebral Palsy, run by Mette Røn Kristensen at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Development of hip displacement or not measured by the Migration Percentage (time frame: Follow-up period of three years.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04403178, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in